Trials / Completed
CompletedNCT01494753
Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the pharmacokinetics, efficacy and safety of T2345 versus an active comparator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T2345 | One drop at 8.00pm. |
| DRUG | Prostaglandin | One drop at 8.00pm. |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2011-12-19
- Last updated
- 2024-02-07
- Results posted
- 2015-01-06
Source: ClinicalTrials.gov record NCT01494753. Inclusion in this directory is not an endorsement.